✦ LIBER ✦

Safety, Pharmacokinetics and Biodistribution Studies of a β-galactoside Prodrug of Doxorubicin for Improvement of Tumor Selective Chemotherapy

✍ Scribed by Devalapally, Harikrishna; Rajan, Kombu Subramanian; Akkinepally, RaghuRam Rao; Devarakonda, Rama Krishna

Book ID: 121857239
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 149 KB
Volume: 34
Category: Article
ISSN: 0363-9045
DOI: 10.1080/03639040701744202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A methylester of the glucuronide prodrug

A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy

✍ Michelle de Graaf; Tapio J. Nevalainen; Hans W. Scheeren; Herbert M. Pinedo; Hid 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 237 KB

601 A First-in-human, Phase 1 Clinical S

601 A First-in-human, Phase 1 Clinical Study of the Safety, Tolerability and Pharmacokinetics (PK) of G-202, a Thapsigargin-based PSMA-activated Prodrug, in Patients with Advanced Solid Tumors

✍ Mahalingam, D.; Wilding, G.; Denmeade, S.; Sarantopoulas, J.; Cosgrove, D.; Cetn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

50 A phase I study of the safety, tolera

50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

✍ H. Richly; S.D. Rubin; A. Madi; M. Jeffels; B. Nokay; D. Gibson; S. Weller; M.E. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

97 POSTER A phase I dose-escalation stud

97 POSTER A phase I dose-escalation study of the safety and pharmacokinetics of a novel spectrum selective kinase inhibitor, XL820, administered orally to patients with solid tumors

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Safety and efficacy of a multicenter stu

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors

✍ Nancy D. Doolittle; Michael E. Miner; Walter A. Hall; Tali Siegal; E. Jerome Han 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 2 views

The aim of this study was to determine the safety and efficacy of intraarterial chemotherapy with osmotic opening of the blood-brain barrier (BBB) for the treatment of malignant brain tumors when administered across multiple centers.

A phase II prospective study of sequenti

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors

✍ Amy Rosenfeld; Morris Kletzel; Reggie Duerst; David Jacobsohn; Paul Haut; Joanna 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 266 KB